Mounjaro for Weight Loss
in India — Tirzepatide
India's most powerful DCGI-approved weight loss injection. Average 20.9% body weight loss in clinical trials — significantly more than Ozempic. Supervised by Dr. Manuj Sondhi, MRCP UK, at Nirvana Clinic, Greater Noida.
The Most Effective Weight Loss Injection Available in India
Mounjaro (tirzepatide) is a once-weekly injectable medication by Eli Lilly, approved by India's DCGI (Central Drugs Standard Control Organisation) and launched in India in March 2025. It is the most clinically effective weight loss medication currently available in India — producing almost twice the weight loss of Ozempic (semaglutide) in head-to-head trials.
What makes Mounjaro unique is its dual-hormone mechanism. Unlike Ozempic, which targets only the GLP-1 receptor, Mounjaro activates both GIP and GLP-1 receptors — the two gut hormones that control appetite, satiety, insulin sensitivity, and fat metabolism. This dual action is why it produces superior weight loss results.
In the landmark SURMOUNT-1 trial, patients on tirzepatide 15mg lost an average of 20.9% of their body weight over 72 weeks — roughly 22–25 kg for most participants. The SURMOUNT-5 head-to-head trial directly compared tirzepatide against semaglutide and found tirzepatide produced 47% more weight loss (20.2% vs 13.7%).
In India, Mounjaro is prescribed for adults with BMI ≥30 (obesity), or BMI ≥27 with weight-related conditions such as Type 2 Diabetes, hypertension, high cholesterol, PCOS, or fatty liver. It must be taken under medical supervision — self-medication carries serious risks.
"Mounjaro is the most significant advance in obesity medicine I have seen in clinical practice. For patients who have struggled for years with weight and metabolic disease, the results are genuinely transformative — but only when prescribed appropriately, monitored carefully, and combined with lifestyle changes."— Dr. Manuj Sondhi, MRCP UK, Diabetologist & GLP-1 Specialist, Nirvana Clinic, Greater Noida
Mounjaro Price in India — All Doses
Launched at 5–6x lower than US pricing. Starting dose is 2.5mg — titrated up over months based on your response and tolerance.
Mounjaro vs Ozempic — Which is Better for Weight Loss?
Based on SURMOUNT-5, the first randomised head-to-head trial (NEJM, 2024). Both are available in India — here's what the evidence shows.
(Tirzepatide)
(Semaglutide)
Sources: SURMOUNT-5 (NEJM 2024), SURMOUNT-1 (NEJM 2022), STEP-1 (NEJM 2021). Both medications require prescription and medical supervision.
Who Should — and Should Not — Take Mounjaro
How Mounjaro Treatment Works at Nirvana Clinic
A medically supervised programme — not a prescription-and-send-away service. Dr. Manuj monitors your progress at every step.
Full clinical evaluation — BMI, blood tests (HbA1c, kidney, liver, lipids, thyroid), medical history, and weight loss goals. Assess suitability for Mounjaro.
Start at 2.5mg weekly. Detailed injection technique guidance. Side effect management plan. Dietary and activity recommendations from day one.
Dose increased every 4 weeks as tolerated — 2.5mg → 5mg → 7.5mg → 10mg → 12.5mg → 15mg. Progress tracked with weight, HbA1c, and labs.
At target weight, a structured maintenance and taper plan. Lifestyle anchoring to prevent weight regain. Long-term follow-up as needed.
Senior Consultant Physician & Diabetologist — Nirvana Clinic & Fortis Hospital, Greater Noida
As an MRCP UK-qualified diabetologist and metabolic specialist, Dr. Manuj is one of the most qualified GLP-1 prescribers in Delhi NCR. His training at Tata Memorial Hospital (Infectious Diseases) and Fellowship in Diabetes from the Royal College of Physicians UK means he understands the complex metabolic picture behind obesity — not just the weight number on a scale. He has been prescribing Ozempic and Mounjaro since their India availability, and takes a thorough, evidence-based approach to patient selection, dosing, and monitoring.
Mounjaro India — Frequently Asked Questions
QIs Mounjaro approved in India for weight loss?▼
Yes. Mounjaro (tirzepatide) is DCGI-approved and was launched in India in March 2025. It is prescribed for Type 2 Diabetes and for obesity management in adults with BMI ≥30, or BMI ≥27 with metabolic comorbidities like hypertension, PCOS, or diabetes. It must be taken under medical supervision.
QWhat is the price of Mounjaro in India?▼
Mounjaro in India costs ₹3,500 per 2.5mg vial and ₹4,375 per 5mg vial — approximately ₹14,000 to ₹17,500 per month at starting doses. KwikPen versions range from ₹13,125 to ₹25,781 per month depending on dose. This is 5–6x cheaper than the US price of approximately $1,086/month.
QHow much weight can I expect to lose with Mounjaro?▼
In the SURMOUNT-1 trial, patients on 15mg tirzepatide lost an average of 20.9% of their body weight over 72 weeks — roughly 22–25 kg for a 100 kg patient. In early adopter Indian clinics, 12–18% weight reduction in 6 months is commonly reported. Results depend on starting weight, dose achieved, and lifestyle adherence.
QIs Mounjaro better than Ozempic for weight loss?▼
Clinical evidence shows Mounjaro produces significantly more weight loss than Ozempic or Wegovy. The SURMOUNT-5 head-to-head trial (NEJM 2024) found tirzepatide produced 20.2% weight loss vs 13.7% for semaglutide — a 47% relative improvement. Mounjaro's dual GIP+GLP-1 mechanism is why it outperforms semaglutide's single GLP-1 action.
QWhat are the side effects of Mounjaro?▼
The most common side effects are nausea, diarrhoea, constipation, vomiting, and reduced appetite — particularly during dose escalation. These are usually mild and improve with time. Slower dose titration significantly reduces side effects. Rare but serious risks include pancreatitis, gallbladder disease, and kidney injury from dehydration — which is why medical supervision is essential.
QWill I regain weight after stopping Mounjaro?▼
Studies show that most patients regain weight after stopping tirzepatide unless they maintain lifestyle changes. A 2023 trial showed patients regained up to 14% of lost weight after 6 months off the drug without a structured maintenance plan. This is why Dr. Manuj's programme includes a structured taper and long-term lifestyle anchoring phase.
QHow to start Mounjaro treatment in Greater Noida?▼
Call or WhatsApp Dr. Manuj Sondhi at +91 8800262767. Nirvana Clinic, Shop GF-93, Sun Twilight Mall, Opposite Delta 1 Metro Station, Greater Noida. A full consultation with blood tests is required before starting. Same-day appointments often available, Mon–Sat 9 AM to 8 PM.
QIs Mounjaro safe for PCOS-related weight gain?▼
Yes — Mounjaro is particularly well-suited for women with PCOS and obesity, as its dual mechanism improves insulin resistance (a key driver of PCOS weight gain) while also suppressing appetite. Dr. Manuj has experience prescribing tirzepatide for women with PCOS-related metabolic dysfunction. A proper hormonal assessment is done before starting.
Start Your Mounjaro Journey — Greater Noida
Sun Twilight Mall
Opp. Delta 1 Metro Station
Greater Noida, UP 201308
9:00 AM – 8:00 PM
Sunday — Closed
Same-day appointments available
India's Most Effective Weight Loss Injection — Now Available in Greater Noida
Mounjaro (Tirzepatide) · DCGI-Approved · 20.9% avg weight loss · Supervised by Dr. Manuj Sondhi MRCP UK
₹14,000/month starting · Same-day appointments Mon–Sat